(Q28743688)

English

Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations

scientific article (publication date: 2011)

Statements

Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Igor Nudelman
0 references
Timor Baasov
0 references
2011
0 references
0 references
6
0 references
6
0 references
e20733
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit